Nasdaq · Surgical & Medical Instruments & Apparatus
14 entities across 10 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-03-12 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| LCP Edge Intermediate, LLC | Delaware | |
| Edge Systems Holdings Corporation | Delaware | |
| Edge Systems Intermediate, LLC | Delaware | |
| Esthetic Medical Inc. | California | |
| HydraFacial LLC | California | |
| The HydraFacial Company Mexico Holdings, LLC | Delaware | |
| The HydraFacial Company MX, S. de R.L. de C.V. | Mexico | |
| HydraFacial Australia and New Zealand Pty Ltd. | Australia | |
| HydraFacial Trading (Shanghai) Co., Ltd. | China | |
| HydraFacial France | France | |
| The HydraFacial Company Iberia, S.L.U | Spain | |
| HydraFacial UK Limited | United Kingdom | |
| Hydrafacial Canada Esthetic Products Inc. | Canada | |
| HydraFacial Germany GmbH | Germany |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $119.1M | −$1.1M | −$15.9M | 56.4% | 34,293,271 |
| FY2021 | $260.1M | −$375.1M | −$39.6M | 69.9% | 102,114,949 |
| FY2022 | $365.9M | $44.4M | −$117.4M | 68.4% | 148,506,312 |
| FY2023 | $398.0M | −$100.1M | $17.9M | 39.0% | 131,680,605 |
| FY2024 | $334.3M | −$29.1M | $15.4M | 54.5% | 142,492,575 |
| FY2025 | $300.8M | −$9.5M | $37.2M | 65.3% | 135,798,202 |
12 institutions tracked — 3 added, 8 reduced, 1 opened a new position.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| FMR LLC | Active fund | 10,201,685 | −6,981,546 | $7.1B |
| STATE STREET CORP | Index | 387,150 | −1,496,877 | $268.1M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 960,374 | −1,281,222 | $665.4M |
| BlackRock, Inc. | Index | 8,516,203 | +1,158,589 | $5.9B |
| CITADEL ADVISORS LLC | Hedge fund | 193,100 | +107,120 | $133.7M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 364,691 | +80,900 | $252.5M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 69,430 | −62,434 | $49,000 |
| JPMORGAN CHASE & CO | Active fund | 2,553 | −47,121 | $1.8M |
| BANK OF AMERICA CORP /DE/ | Active fund | 72,567 | −33,675 | $50.2M |
| MORGAN STANLEY | Active fund | 36,821 | −28,993 | $25.5M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 483,908 | −16,176 | $335.1M |
Point72 Asset Management, L.P. holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
SkinHealth Systems Inc. files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
Where dealer gamma sat in SKIN’s option chain after the close on 2026-09-01, aggregated from the full chain. This is a once-a-day snapshot, not a live read — 16 contracts.
Computed from the listed option chain by my own aggregation, once, after the close — it describes where positioning sat that evening and does not update through the next session. The version that rebuilds per strike while the market is open is the intraday gamma product. Not investment advice.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.